[Federal Register Volume 72, Number 2 (Thursday, January 4, 2007)]
[Presidential Documents]
[Pages 429-430]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: X07-10104]



[[Page 427]]

-----------------------------------------------------------------------

Part V





The President





-----------------------------------------------------------------------



Proclamation 8095--To Eliminate Tariffs on Certain Pharmaceuticals and 
Chemical Intermediates



Proclamation 8096--To Extend Nondiscriminatory Treatment (Normal Trade 
Relations Treatment) to the Products of Vietnam



Proclamation 8097--To Modify the Harmonized Tariff Schedule of the 
United States, To Adjust Rules of Origin Under the United States-
Australia Free Trade Agreement and for Other Purposes



Proclamation 8098--To Take Certain Actions Under the African Growth and 
Opportunity Act and the Generalized System of Preferences



                        Presidential Documents 



Federal Register / Vol. 72, No. 2 / Thursday, January 4, 2007 / 
Presidential Documents

___________________________________________________________________

Title 3--
The President

[[Page 429]]

                Proclamation 8095 of December 29, 2006

                
To Eliminate Tariffs on Certain Pharmaceuticals 
                and Chemical Intermediates

                By the President of the United States of America

                A Proclamation

                1. During the Uruguay Round of Multilateral Trade 
                Negotiations (the ``Uruguay Round''), a group of major 
                trading countries agreed to reciprocal elimination of 
                tariffs on certain pharmaceuticals and chemical 
                intermediates, and that participants in this agreement 
                would revise periodically the list of products subject 
                to duty-free treatment. On December 13, 1996, at the 
                Ministerial Conference of the World Trade Organization 
                (WTO), the United States and 16 other major trading 
                countries agreed to eliminate tariffs on additional 
                pharmaceuticals and chemical intermediates. On April 1, 
                1997, the United States implemented this agreement in 
                Proclamation 6982. The second revision to the list of 
                products was negotiated under the auspices of the WTO 
                in 1998. The United States implemented this revision on 
                July 1, 1999, in Proclamation 7207. In 2006, the United 
                States and 30 other WTO members concluded negotiations, 
                under the auspices of the WTO, on a further revision to 
                the list of pharmaceuticals and chemical intermediates 
                to receive duty-free treatment.

                2. Section 111(b) of the Uruguay Round Agreements Act 
                (URAA)(19 U.S.C. 3521(b)) authorizes the President 
                under specified circumstances to proclaim the 
                modification of any duty or staged rate reduction of 
                any duty set forth in Schedule XX-United States of 
                America, annexed to the Marrakesh Protocol to the GATT 
                1994 (Schedule XX) for products that were the subject 
                of reciprocal duty elimination negotiations during the 
                Uruguay Round, if the United States agrees to such 
                action in a multilateral negotiation under the auspices 
                of the WTO. Section 111(b) also authorizes the 
                President to proclaim such modifications as are 
                necessary to correct technical errors in, or make other 
                rectifications to, Schedule XX.

                3. On October 3, 2006, consistent with section 115 of 
                the URAA, the United States Trade Representative (USTR) 
                submitted a report to the Committee on Ways and Means 
                of the House of Representatives and the Committee on 
                Finance of the Senate (the ``Committees'') that set 
                forth the proposed further revision to the list of 
                products subject to tariff eliminations.

                4. Section 604 of the Trade Act, as amended (19 U.S.C. 
                2483), authorizes the President to embody in the 
                Harmonized Tariff Schedule of the United States (HTS) 
                the substance of the relevant provisions of that Act, 
                and of other acts affecting import treatment, and 
                actions thereunder, including the removal, 
                modification, continuance, or imposition of any rate of 
                duty or other import restriction.

                5. Pursuant to section 111(b) of the URAA, I have 
                determined that Schedule XX should be modified to 
                reflect the implementation by the United States of the 
                multilateral agreement on certain pharmaceuticals and 
                chemical intermediates negotiated under the auspices of 
                the WTO. In addition, I have determined that the 
                pharmaceuticals appendix to the HTS should be modified 
                to reflect the duty eliminations provided for in that 
                agreement and to make certain technical corrections in 
                the manner in which Schedule XX identifies

[[Page 430]]

                particular products in order to ensure that they are 
                accorded the intended duty treatment.

                NOW, THEREFORE, I, GEORGE W. BUSH, President of the 
                United States of America, acting under the authority 
                vested in me by the Constitution and the laws of the 
                United States of America, including but not limited to 
                section 111(b) of the URAA and section 604 of the 1974 
                Act, do proclaim that:

                (1) In order to implement the multilateral agreement 
                negotiated under the auspices of the WTO to eliminate 
                tariffs on certain pharmaceutical products and chemical 
                intermediates, and to make technical corrections in the 
                tariff treatment accorded to such products, the HTS is 
                modified as set forth in the Annex to this 
                proclamation.

                (2) Such modifications to the HTS shall be effective 
                with respect to articles entered, or withdrawn from 
                warehouse for consumption, on or after the date set 
                forth in the Annex for the respective actions taken.

                (3) Any provisions of previous proclamations and 
                Executive Orders that are inconsistent with the actions 
                taken in this proclamation are superseded to the extent 
                of such inconsistency.

                IN WITNESS WHEREOF, I have hereunto set my hand this 
                twenty-ninth day of December, in the year of our Lord 
                two thousand six, and of the Independence of the United 
                States of America the two hundred and thirty-first. 
                
                
                    (Presidential Sig.)

Billing code 3195-01-P